The first choice of pharmacological treatment for MDD and most anxiety disorders are selective serotonin reuptake inhibitors (SSRIs) [5, 6], blocking the 5-HT transporter (5-HTT) [7]. Here, SLC6A4 is linked to anxiety disorder.